Homocysteine, an amino acid containing a sulfhydryl group, is an intermediate product
during metabolism of the amino acids methionine and cysteine. Hyperhomocysteinemia is …

Increased plasma homocysteine (Hcy) is a significant and independent risk factor for
cardiovascular disease. It can cause multi-disease manifestations such as smooth muscle …

Homocysteine, a sulphur-containing amino acid derived from methionine, has been
presented as an independent risk factor for cardiovascular disorders, including …

In the last 10 years, homocysteine has been regarded as a marker of cardiovascular disease
and a definite risk factor for many other diseases. Homocysteine is biosynthesized from …

Homocysteine (Hcy) is a sulfhydryl-containing amino acid, and intermediate metabolite
formed in metabolising methionine (Met) to cysteine (Cys); defective Met metabolism can …

Mild hyperhomocysteinemia has been suggested as a new, independent risk factor for
cardiovascular disease. This fact has produced a new, increased interest in the study of …

Elevated plasma levels of homocysteine are a metabolic risk factor for atherosclerotic
vascular disease, as shown in numerous clinical studies that linked elevated homocysteine …

Elevated plasma levels of the amino acid homocysteine increase the risk for atherosclerosis,
stroke, myocardial infarction, and possibly Alzheimer's disease. In relation to vascular …

Homocysteine, a non-protein amino acid, is an important risk factor for ischemic heart
disease and stroke in humans. This review provides an overview of homocysteine influence …

Elevated plasma homocysteine is an independent risk factor for atherosclerosis and
thrombosis. The exact mechanism by which homocysteine exerts its atherothrombotic action …